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Abstract
Background: Non-invasive brain stimulation-related seizures or syncopal events are rare. However, we report on a
syncopal event in a healthy female during a transcranial magnetic stimulation single-pulse testing session.
Case presentation: A 47-year-old healthy female presented for a transcranial magnetic stimulation session
involving single-pulse assessment of cortical excitability. During the session, the participant appeared to have a brief
event involving fainting and myoclonic jerks of the upper extremities. Orthostatic assessment was performed after
the event and physician evaluation determined that this was a vasovagal syncopal event. The ethical aspects of this
neurophysiology testing protocol were reviewed by the University of Minnesota Institutional Review Board (IRB),
and formal IRB approval was deemed unnecessary for single-pulse assessment of healthy control participants not
directly involved in a research study. Informed consent was obtained by the participant, including review of
potential adverse events.
Conclusion: Although rare and rarely reported, vasovagal syncopal events surrounding non-invasive brain
stimulation do occur. Thorough pre-screening should incorporate assessment of history of syncope and a plan for
risk mitigation if such an event should occur. A complete assessment of the impact of stimulation on the
autonomic nervous system is unknown. As such studies expand into patients with myriad neurologic diagnoses,
further studies on this effect, in both healthy control and patient populations, are warranted. Such knowledge could
contribute to identification of the optimal study participant, and improvements in techniques of stimulation
administration.
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Background
Transcranial magnetic stimulation (TMS) involves the
application of a transient magnetic field external to the
skull, in single or repetitive fashion, to induce neuronal
depolarization. Rarely, seizure activity has been reported
in cases involving both single and repetitive-pulse TMS
[1]. TMS-related syncopal events, or non-epileptiform
loss of consciousness due to transient alteration of blood
pressure and/or heart rate, have also been reported in
rare instances [2, 3]. Vasovagal syncope (VVS), also
referred to as reflex or neurally-mediated syncope, mani-
fests as a transient loss of consciousness secondary a
brief drop in systemic blood pressure and/or heart rate
in response to emotional distress leading to global cere-
bral hypoperfusion [4]. We report a case of VVS associ-
ated with TMS in an otherwise healthy adult participant.
Case presentation
A 47 year old, right-handed female was recruited as a
healthy control participant to undergo TMS testing over
the primary motor cortex. The participant reported
medical history of hypothyroidism s/p partial thyroidec-
tomy in 2007 with a daily 75 mcg tablet of oral levothyr-
oxine as her only medication. No risk factors of prior
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closed head injury, loss of consciousness, history of seiz-
ure or febrile seizures, history of epilepsy or fainting
were reported at the start of the TMS session. On the
day of testing, the participant reported normal sleep, no
changes in medication, no illicit drug use or usage of al-
cohol or caffeine.. The participant reported no symp-
toms at baseline on an IRB approved questionnaire.
Transcranial magnetic stimulation
Baseline blood pressure and heart rate were 110/64
mmHg and 66 beats per minute, (bpm), respectively. She
was positioned in 30° reclined seated position in a Brain-
sight TMS chair for TMS testing (Brainsight, Montreal,
Canada). Surface Ag-AgCl bipolar recording electrodes
were placed over the right hand first dorsal interosseous
muscle after skin cleansing with an alcohol pad. A head-
band with stereotactic neuronavigation tracking software
was applied to forehead with no discomfort reported by
the participant.
Single-pulses of TMS were delivered using a Magstim
Bistim2 and 2002 set with a 70 mm, figure-eight coil
(Magstim Company Ltd., Dyfed, UK). The location of
the left cortical motor threshold was determined by pla-
cing the coil 45° from perpendicular over the posterior
frontal head region at the primary motor cortex hotspot
for hand representation. Criteria for localizing the motor
hotspot was determined through obtaining a motor
evoked potential of at least 50 uV in amplitude on 3/5
trials using a Motion-Lab electromyography system
(Y03-2, Motion Lab Systems, Inc., Baton Rouge, LA,
USA) with custom made LabView software (v2012,
National Instruments, Austin, TX, USA). The resting
motor threshold was determined to be at 50 % machine
maximum stimulus intensity. The participant reported
no discomfort during resting motor threshold testing.
The testing proceeded to obtain 1 mV motor evoked po-
tentials with TMS over the left motor hotspot starting
with stimulus intensity 120 % of the resting motor
threshold (60 % machine maximum). Stimulus intensity
was then increased to 65, 67 and 70 % of machine max-
imum with stimulus intervals of ≥20 s.
Syncopal event
Approximately thirty minutes into the testing session
and upon the 128th pulse on the left hemisphere, the
participant reported feeling “queasy”. Testing was imme-
diately stopped and the participant was offered a glass of
water. The participant then reported feeling “dizzy” and
the water was removed from her hand. Two minutes
after the last magnetic stimulation, the participant ap-
peared to have fainted. The TMS operator noted that
the participant’s face was pale for 10 s prior to loss of
consciousness. The participant turned her face to the left
with her eyes remaining closed. Her left arm assumed a
flexed posture with what appeared to be myoclonic type
jerking for 2–3 s in duration. Jerking activity was also
noted in the right arm but not to the same intensity. No
motor movements were noted involving the lower ex-
tremities. All electrodes were detached, and when the
jerking movements of the upper extremities ceased, the
participant was reclined to the full horizontal position.
After cessation of the jerking movements, the partici-
pant’s eyes remained closed and responded “yes” to the
TMS operator question on whether or not she could
hear the operator. In the reclined position, and approxi-
mately nine minutes after loss of consciousness, her
blood pressure and pulse were recorded as 110/61
mmHg and 61 bpm respectively. The participant re-
ported that when the symptoms started, she felt that she
was “not seeing clearly” and “started to get warm”. She
did not have any urinary or fecal incontinence, nor post-
event confusion or trauma. The participant felt she
could ambulate and the session was ended.
Post-event assessment
The participant was then escorted to an urgent care clinic,
where a mental status, general and neurologic examination
were performed by an internal medicine physician. Ortho-
static vital sign testing was normal with supine and imme-
diate standing blood pressure and pulse of 108/74 mmHg,
78 bpm and 123/86 mmHg, 95 bpm, respectively. Cardio-
vascular and neurologic examinations were noted to be
normal. The participant reported normal intake of food
and water on this day, and the evaluating physician did not
conclude it necessary to perform a blood glucose test. The
participant noted upon specific questioning of “have you
personally ever fainted?” instead of “do you have a history
of fainting?” to have had a single syncopal episode, ap-
proximately 10 years ago, while donating blood. The par-
ticipant stated that her interpretation of our original
questioning “do you have a history of fainting?” pertained
to a family history, not personal, history of fainting events.
The urgent care physician determined the diagnosis as
VVS based on past history of syncope, absence of fecal or
urinary continence, full recall of the event without confu-
sion, and stability of vital signs on orthostatic assessment.
Based on the diagnosis of VVS, the physician determined
that serum chemistries, electroencephalography and brain
imaging were not indicated. The electrophysiology labora-
tory and urgent care notes were further reviewed by the
study neurologist who concurred with the diagnosis of
VVS. At one, four and twelve-week phone follow-up with
the participant, no further symptoms were reported.
Conclusions
VVS may occur rarely in association with TMS, but ap-
pears to be a benign symptom without delayed morbid-
ity. Myoclonic muscle jerking has been reported in up to
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27 % of subjects with observed VVS, and it is important
not to confuse this motor phenomenon with seizure ac-
tivity, as VVS is felt to be a more benign clinical entity
generally requiring no further laboratory investigation
[5, 6]. VVS events occur more often in younger individ-
uals and women, and attacks are commonly triggered by
anxiety, noxious stimuli, prolonged standing and in-
creased thoracic pressure [6]. Interestingly, our partici-
pant reported no anxiety or discomfort with the TMS
procedure prior to loss of consciousness. Therefore, it is
unclear as to whether this episode of VVS was secondary
to an emotional response or direct effect of TMS on
autonomic nervous system function. We recommend
that participants undergoing TMS should be screened
thoroughly for any history of syncopal events prior to
undergoing the procedure. Additionally, creating screen-
ing questionnaires which are readily understood by the
population studied can elucidate and detail a more
complete medical history. Such information will allow
consideration of any/all medical diagnoses and medica-
tions (i.e.-thyroid hormones and centrally-acting medica-
tions) which may influence cortical excitability and the
potential for syncopal or seizure activity [7, 8]. Real-time
integration of TMS with electroencephalography (EEG)
is also recommended for surveillance of underlying ictal
brain activity during TMS administration [1]. Further
studies of the effects of TMS on autonomic nervous sys-
tem function are also warranted to investigate the im-
pact of non-invasive brain stimulation interventions in
populations with and without specific history of auto-
nomic nervous system dysfunction.
Consent
Written informed consent was obtained from the par-
ticipant for publication of this Case report and any ac-
companying images. A copy of the written consent is
available for review by the Editor of this journal.
Abbreviations
TMS: Transcranial magnetic stimulation; VVS: Vasovagal syncope.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
BTG: conceiving and designing the study, funding, data acquisition,
manuscript development and manuscript writing. TR: manuscript
development, data acquisition, manuscript writing and manuscript
authorization. MC: manuscript development, data acquisition, manuscript
writing and manuscript authorization. GM: manuscript development, data
acquisition, manuscript writing and manuscript authorization. Neurologist
review of case. All authors read and approved the final manuscript.
Acknowledgments
BTG funding by NIH/NICHD 5 K01-HD078484-02, Cerebral Palsy Foundation,
Foundation for Physical Therapy. TR funding MnDRIVE.
Author details
1University of Minnesota Medical School, Rehabilitation Science, 420
Delaware Street SE, MMC 388, Minneapolis, MN 55455, USA. 2Institute for
Engineering in Medicine, University of Minnesota Non-Invasive
Neuromodulation Laboratory, MnDRIVE Brain Conditions, 420 Delaware
Street SE, MMC 388, Minneapolis, MN 55455, USA. 3University of Minnesota
Medical School, Department of Neurology, Minneapolis, MN 55455, USA.
Received: 22 September 2015 Accepted: 27 November 2015
References
1. Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Safety of TMS Consensus
Group. Safety, ethical considerations, and application guidelines for the use
of transcranial magnetic stimulation in clinical practice and research. Clin
Neurophysiol. 2009;120(12):2008–39. doi:10.1016/j.clinph.2009.08.016.
2. Kirton A, Deveber G, Gunraj C, Chen R. Neurocardiogenic syncope
complicating pediatric transcranial magnetic stimulation. Pediatr Neurol.
2008;39(3):196–7.
3. Sczesny-Kaiser M, Höffken O, Tegenthoff M, Schwenkreis P. Convulsive
syncope after single-pulse TMS. Brain Stimulation. 2013;6(5):830. doi:10.1016/
j.brs.2013.01.018.
4. Moya A, Sutton R, Ammirati F, Blanc J, Brignole M, Dahm JB, et al.
Guidelines for the diagnosis and management of syncope (version 2009).
Eur Heart J. 2009;30(21):2631–71. doi:10.1093/eurheartj/ehp298.
5. Romme JJCM, van Dijk N, Boer KR, Bossuyt PMM, Wieling W, Reitsma JB.
Diagnosing vasovagal syncope based on quantitative history-taking:
Validation of the calgary syncope symptom score. Eur Heart J. 2009;30(23):
2888–96. doi:10.1093/eurheartj/ehp314.
6. Romme JJCM, van Dijk N, Boer KR, Dekker LRC, Stam J, Reitsma JB, et al.
Influence of age and gender on the occurrence and presentation of reflex
syncope. Clin Auton Res. 2008;18(3):127–33. doi:10.1007/s10286-008-0465-0.
7. Rizzo V, Crupi D, Bagnato S, Quartarone A, Benvenga S, Bartolone L, et al.
Neural response to transcranial magnetic stimulation in adult
hypothyroidism and effect of replacement treatment. J Neurol Sci. 2008;
266(1–2):38–43. Epub 2007 Sep 27.
8. Tamijani SM, Karimi B, Amini E, Golpich M, Dargahi L, Ali RA, et al. Thyroid
hormones: possible roles in epilepsy pathology. Seizure. 2015;31:155–64.
doi:10.1016/j.seizure.2015.07.021. Epub 2015 Aug 4.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Gillick et al. BMC Neurology  (2015) 15:248 Page 3 of 3
